Diamond Biofund Inc. (TPE: 6901)
Taiwan
· Delayed Price · Currency is TWD 31.50
+0.40 (1.29%)
Jan 22, 2025, 1:30 PM CST
Diamond Biofund Revenue
Diamond Biofund had revenue of -756.69M TWD in the quarter ending September 30, 2024, a decrease of -39.73%. This brings the company's revenue in the last twelve months to -1.41B, down -61.82% year-over-year. In the year 2023, Diamond Biofund had annual revenue of -2.44B, down -340.20%.
Revenue (ttm)
-1.41B
Revenue Growth
-61.82%
P/S Ratio
n/a
Revenue / Employee
-50.24M
Employees
28
Market Cap
26.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | -2.44B | -3.46B | -340.20% |
| Dec 31, 2022 | 1.02B | -2.05B | -66.85% |
| Dec 31, 2021 | 3.06B | -3.44B | -52.88% |
| Dec 31, 2020 | 6.50B | 6.80B | -2,243.38% |
| Dec 31, 2019 | -303.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fubon Financial Holding | 838.60B |
| Cathay Financial Holding | 1,008.18B |
| CTBC Financial Holding | 503.95B |
| Mega Financial Holding | 77.35B |
| Yuanta Financial Holding | 179.63B |
| E.SUN Financial Holding Company | 72.11B |
| First Financial Holding | 64.30B |
| Hua Nan Financial Holdings | 61.40B |